Performance deficit induced by low doses of dopamine agonists in rats toward a model for approaching the neurobiology of negative schizophrenic symptomatology?
- 1 January 1986
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 21 (1) , 11-22
- https://doi.org/10.1016/0006-3223(86)90004-1
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Dopamine and schizophrenia: An analysis of the theoryNeuroscience & Biobehavioral Reviews, 1984
- Avoidance and ICSS behavioral models dissociate TL-99 and 3-PPP from dopamine receptor antagonistsEuropean Journal of Pharmacology, 1983
- Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neuronsJournal of Neuroscience, 1983
- Stimulation of rat spontaneous locomotion by low doses of haloperidol and (−)-sulpiride: Importance of animal selection and measurement techniqueEuropean Journal of Pharmacology, 1983
- Negative v Positive SchizophreniaArchives of General Psychiatry, 1982
- Response Artifact in the Measurement of Neuroleptic-Induced AnhedoniaScience, 1981
- Characterisation of the mechanisms by which purported dopamine agonists reduce spontaneous locomotor activity of miceEuropean Journal of Pharmacology, 1981
- Neuroleptic antagonism of the motor inhibitory effects of apomorphine within the nucleus accumbens: Drug interaction at presynaptic receptors?European Journal of Pharmacology, 1980
- Molecular pathology of schizophrenia: more than one disease process?BMJ, 1980
- Evidence for dopamine receptors mediating sedation in the mouse brainNature, 1976